| Randall J Rouse, MD | |
|
701 Dellwood St S, Cambridge, MN 55008-1920 | |
| (763) 689-8700 | |
| (763) 689-7941 |
| Full Name | Randall J Rouse |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 701 Dellwood St S, Cambridge, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467460055 | NPI | - | NPPES |
| 716870500 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35813 (Minnesota) | Primary |
| 207P00000X | Emergency Medicine | 35813 (Minnesota) | Secondary |
| Entity Name | Emergency Physicians Professional Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801871934 PECOS PAC ID: 9537072657 Enrollment ID: O20031106000068 |
News Archive
maxIT Healthcare, LLC and Ingenuity Solutions Group, Inc. announced today that they have entered into a definitive agreement, under which the companies will be combined as maxIT Healthcare. The combined company is now better positioned to extend its presence throughout the healthcare IT professional services market, particularly in the area of Enterprise Resource Planning (ERP) system solutions.
According to a recent Finnish study, boys and girls with attention deficit hyperactivity disorder (ADHD) may differ from each other in their vulnerability to substance use problems. Inattentiveness and hyperactivity may be more predictive of alcohol use disorders and maladaptive patterns of alcohol and illicit drug use among girls than boys.
A Brazilian study, published in Scientific Reports on October 09, 2017, has identified changes in signaling pathways associated with neural plasticity, inflammation and neurodegeneration triggered by a compound from the family of dimethyltryptamine known as 5-MeO-DMT.
Merck, a leading science and technology company, will present data at the ESMO 18th World Congress on Gastrointestinal Cancer from the pivotal Phase III TAILOR study in patients from China, the first prospective trial to evaluate an anti-EGFR antibody in the first-line therapy of patients with RAS wild-type metastatic colorectal cancer (mCRC).
In anticipation of the Sixteen Days of Activism Against Gender Violence, a campaign which starts on the International Day for the Elimination of Violence Against Women on November 25, Daniela Ligiero, senior adviser for gender at the Office of the Global AIDS Coordinator, reports on PEPFAR's commitment to address gender-based violence in this post in the Department of State's "DipNote" blog.
› Verified 5 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
maxIT Healthcare, LLC and Ingenuity Solutions Group, Inc. announced today that they have entered into a definitive agreement, under which the companies will be combined as maxIT Healthcare. The combined company is now better positioned to extend its presence throughout the healthcare IT professional services market, particularly in the area of Enterprise Resource Planning (ERP) system solutions.
According to a recent Finnish study, boys and girls with attention deficit hyperactivity disorder (ADHD) may differ from each other in their vulnerability to substance use problems. Inattentiveness and hyperactivity may be more predictive of alcohol use disorders and maladaptive patterns of alcohol and illicit drug use among girls than boys.
A Brazilian study, published in Scientific Reports on October 09, 2017, has identified changes in signaling pathways associated with neural plasticity, inflammation and neurodegeneration triggered by a compound from the family of dimethyltryptamine known as 5-MeO-DMT.
Merck, a leading science and technology company, will present data at the ESMO 18th World Congress on Gastrointestinal Cancer from the pivotal Phase III TAILOR study in patients from China, the first prospective trial to evaluate an anti-EGFR antibody in the first-line therapy of patients with RAS wild-type metastatic colorectal cancer (mCRC).
In anticipation of the Sixteen Days of Activism Against Gender Violence, a campaign which starts on the International Day for the Elimination of Violence Against Women on November 25, Daniela Ligiero, senior adviser for gender at the Office of the Global AIDS Coordinator, reports on PEPFAR's commitment to address gender-based violence in this post in the Department of State's "DipNote" blog.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Randall J Rouse, MD 2925 Chicago Avenue, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | Randall J Rouse, MD 701 Dellwood St S, Cambridge, MN 55008-1920 Ph: (763) 689-8700 |
News Archive
maxIT Healthcare, LLC and Ingenuity Solutions Group, Inc. announced today that they have entered into a definitive agreement, under which the companies will be combined as maxIT Healthcare. The combined company is now better positioned to extend its presence throughout the healthcare IT professional services market, particularly in the area of Enterprise Resource Planning (ERP) system solutions.
According to a recent Finnish study, boys and girls with attention deficit hyperactivity disorder (ADHD) may differ from each other in their vulnerability to substance use problems. Inattentiveness and hyperactivity may be more predictive of alcohol use disorders and maladaptive patterns of alcohol and illicit drug use among girls than boys.
A Brazilian study, published in Scientific Reports on October 09, 2017, has identified changes in signaling pathways associated with neural plasticity, inflammation and neurodegeneration triggered by a compound from the family of dimethyltryptamine known as 5-MeO-DMT.
Merck, a leading science and technology company, will present data at the ESMO 18th World Congress on Gastrointestinal Cancer from the pivotal Phase III TAILOR study in patients from China, the first prospective trial to evaluate an anti-EGFR antibody in the first-line therapy of patients with RAS wild-type metastatic colorectal cancer (mCRC).
In anticipation of the Sixteen Days of Activism Against Gender Violence, a campaign which starts on the International Day for the Elimination of Violence Against Women on November 25, Daniela Ligiero, senior adviser for gender at the Office of the Global AIDS Coordinator, reports on PEPFAR's commitment to address gender-based violence in this post in the Department of State's "DipNote" blog.
› Verified 5 days ago
Dr. Dawn A Schreifels, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 | |
Michael J. Joyce, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cmc, Cambridge, MN 55008 Phone: 763-689-7700 | |
Debra S Larson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 Fax: 763-689-7941 | |
Allen J Mork, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 | |
Robert P Callen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 Fax: 763-689-7941 | |
Daniel Charles Wallace, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 | |
Charles J Phillips, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 Fax: 763-689-7941 |